Attività scientifica

 

Principali pubblicazioni 

 

1. Sindrome dell'Ovaio Policistico

• Carmina E.. Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs. Journal of Clinical Medicine 2023, 12, 5921. https://doi.org/10.3390/jcm12185921 
• Carmina E. Need to Introduce the Finding of Obesity or Normal Body Weight in the Current Diagnostic Criteria and in the Classification of PCOS. Diagnostics 2022; 12(10), 2555
• Carmina E, Nasrallah MP, Guastella E, Lobo RA. Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily. Clin Endocrinol (Oxf). 2019 Jul 15. doi: 10.1111/cen.14063.
• Carmina E, Fruzzetti F, Lobo RA. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea. Am J Obstet Gynecol. 2016; 214:714, 1-6
• Carmina E, Campagna AM, Fruzzetti F, Lobo RA. AMH measurement versus ovarian ultrasound in the diagnosis of polycystic ovary syndrome in different phenotypes. Endocr Pract. 2016 Mar; 22(3):287-93. 
• Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2014 May-Jun; 20(3):334-52. 
• Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010 Sep; 203(3):201.e1-5. 
• Di Fede G, Mansueto P, Pepe I, Rini GB, Carmina E. High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms. Fertil Steril. 2010 Jun; 94(1):194-7. 

2. Complicanze della PCOS

 

1. Welt CK, Carmina E. Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013 Dec; 98(12):4629-38 

2. Carmina E, Campagna AM, Lobo RA. A 20-year follow-up of young women with polycystic ovary syndrome. Obstet Gynecol. 2012 Feb; 119(2 Pt 1):263-9. 

3. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan; 97(1):28-38.e25. 

4. Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011 Mar 1; 95(3):1073-9.e1-11. 

5. Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2019 Aug 6:1-12. doi: 10.1080/09513590.2019.1650337. [Epub ahead of print]
6. Rizzo M, Berneis K, Hersberger M, Pepe I, Di Fede G, Rini GB, Spinas GA, Carmina E. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod. 2009; 24(9):2286-92. 

3.. Disfunzione del tessuto adiposo ed obesità nella PCOS

 

1. Carmina E. Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome. Front Horm Res. 2013; 40:40-50. 

2. Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril. 2009 Apr; 91:1332-5. 

3. Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, Tena G, Preciado R, Lobo R. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril. 2008;89(3):642-8.

4. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, Di Fede G, Rini G. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007 Jul; 92(7):2500-5. 

5. Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, Lobo RA. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol. 2005 Mar; 152(3):389-94. 

4. Iperandrogenismi 

 

• Carmina E, Azziz R, Bergfeld W, Escobar Morreale HF, Futterweit W, Huddleston H, Lobo RA, Olsen E. Female pattern hair loss and androgen excess: a report from the multidisciplinary Androgen Excess and PCOS committee. J Clin Endocrinol Metab. 2019; 104: 2875-2891
• E Carmina, D Dewailly, HF Escobar-Morreale, F Kelestimur, C Moran, Sharon Oberfield, Selma Witchel, Ricardo Azziz. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Human Reproduction Update, 2017; 23:  580–599. 
• E Carmina, F Rosato, A Janni, M Rizzo, RA Longo. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. The Journal of Clinical Endocrinology & Metabolism 2006; 91 (1), 2-6

5. Vitamin D e metabolismo osseo

 

1. E Carmina. Vitamin D: Biological Significance and Diagnosis of Mild Deficiency. Biomarkers in Bone Disease, 2017: 393-400
2. N Napoli, R Strollo, D Sprini, E Maddaloni, GB Rini, E Carmina. Serum 25-OH vitamin D in relation to bone mineral density and bone turnover International journal of endocrinology 2014; 2014:487463.

Lista completa delle pubblicazioni del Professore Enrico Carmina:

La lista completa delle pubblicazioni puo' essere trovata su Google Scholar, Research Gate, Pub Med, e NIH